濠賭股全線下跌 澳門升級防疫措施 明起從陸路口岸入境須持48小時核酸證明
格隆匯1月13日丨濠賭股全線下跌,美高梅中國(2282.HK)跌逾4%,新濠國際跌逾3%,銀河娛樂、澳博控股、金沙中國均跌近3%。澳門新型冠狀病毒感染應變協調中心公佈,因應疫情防控需要,衞生局根據《傳染病防治法》規定,自1月14日零時起,所有由內地經機場以外口岸入境者,須持有采樣日後48小時內符合衞生當局要求的新型冠狀病毒核酸檢測陰性結果證明,未能出示符合要求證明的非澳門居民可被拒絕入境;對離境人士維持出示7天內核酸檢測陰性結果證明的要求。大和近日發研報指,據該行實地考察,1月博彩收益料將延續上月升勢,預計1月日均賭收將介乎於2.4億至2.6億澳門元。但鑑於香港爆發Omicron疫情,加上內地個別地區需要封城或進行大規模檢測,相信通關消息刺激至少需等待到第一季末。該行重申對澳門博彩股“正面”評級,建議投資者可收集優質的濠賭股。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.